Antithrombin III concentrate as adjuvant in DIC treatment. A pilot study in 9 severely ill patients. 1984

M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
November 1994, The Netherlands journal of medicine,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
August 1982, Thrombosis research,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
November 1985, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
January 1983, Bibliotheca haematologica,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
January 1989, Journal of internal medicine,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
September 1989, Annals of internal medicine,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
August 1978, Thrombosis research,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
April 1985, Nihon Sanka Fujinka Gakkai zasshi,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
November 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
M Hellgren, and L Javelin, and K Hägnevik, and M Blombäck
December 2007, BMJ (Clinical research ed.),
Copied contents to your clipboard!